EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Oncohematology Immunotherapy: Monoclonal Antibodies and CAR T-Cell Therapies

Fanny Mathias, Cyril Fersing iD, Véronique Bourgarel iD, Jean Gabert, Florence Peyron

Cells · 10.08.2026 · 15 (16) · 1439

DOI: 10.3390/cells15161439 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 10.08.2026. Verfasst von Fanny Mathias und 4 weiteren Autor:innen. Beteiligte Einrichtung: CNRS, Institut de Chimie Radicalaire ICR, UMR 7273, Equipe de Pharmaco-Chimie Radicalaire, Aix-Marseille University, 13005 Marseille, France. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Immunotherapy, Adoptive, Hematologic Neoplasms, Immunotherapy. Die Arbeit nennt 255 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of immunotherapy in oncohematology is well established. Monoclonal antibodies have undergone substantial development in recent years, targeting a wide range of molecules (including surface antigens, immune checkpoints, and cytokines) and have demonstrated clinical utility across various hematologic malignancies, including leukemias, lymphomas, and myelomas. The emergence of advanced therapy medicinal products (ATMPs), particularly chimeric antigen receptor (CAR) T cells, has provided an additional and promising therapeutic option. This rapidly evolving field continues to expand therapeutic possibilities. The objective of this literature review is to summarize novel immunotherapeutic strategies in oncohematology, including monoclonal antibody- and CAR T-cell-based approaches, and to review the key findings from recent clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalImmunotherapy, AdoptiveHematologic NeoplasmsImmunotherapyReceptors, Chimeric AntigenHumansAnimals

Stichwörter der Autor:innen

CAR T-cellsimmunotherapymonoclonal antibodiesoncohematology

Substanzen

Antibodies, MonoclonalReceptors, Chimeric Antigen

Autor:innen und Institutionen

  • CNRS, Institut de Chimie Radicalaire ICR, UMR 7273, Equipe de Pharmaco-Chimie Radicalaire, Aix-Marseille University, 13005 Marseille, France.
  • Pharmacy Department, Marseille Nord University Hospital Pharmacy, Assistance Publique-Hôpitaux de Marseille, 13015 Marseille, France.
  • Nuclear Medicine Department, Institut Régional du Cancer de Montpellier, Université de Montpellier, 34090 Montpellier, France.
  • IBMM, CNRS, ENSCM, Université de Montpellier, 34090 Montpellier, France.
  • Innovation and Clinical Research Department, Assistance Publique Hôpitaux de Marseille (AP-HM), 13005 Marseille, France.
  • Cancer Research Center of Marseille (CRCM), INSERM UMR1068, CNRS UMR7258, Aix-Marseille University, 13005 Marseille, France.

ORCID-Profile: Cyril Fersing, Véronique Bourgarel

Zitieren

APA

Mathias, F., Fersing, C., Bourgarel, V., Gabert, J., & Peyron, F. (2026). Advances in Oncohematology Immunotherapy: Monoclonal Antibodies and CAR T-Cell Therapies. Cells, 15(16), 1439. https://doi.org/10.3390/cells15161439

Vancouver

Mathias F, Fersing C, Bourgarel V, Gabert J, Peyron F. Advances in Oncohematology Immunotherapy: Monoclonal Antibodies and CAR T-Cell Therapies. Cells. 2026;15(16):1439. doi:10.3390/cells15161439

BibTeX
@article{Mathias2026,
  author = {Mathias, Fanny and Fersing, Cyril and Bourgarel, Véronique and Gabert, Jean and Peyron, Florence},
  title = {Advances in Oncohematology Immunotherapy: Monoclonal Antibodies and CAR T-Cell Therapies},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {16},
  pages = {1439},
  doi = {10.3390/cells15161439}
}
Kostenlos starten →